Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

A randomized controlled study of a consent intervention for participating in an NIH genome sequencing study.

Turbitt E, Chrysostomou PP, Peay HL, Heidlebaugh AR, Nelson LM, Biesecker BB.

Eur J Hum Genet. 2018 May;26(5):622-630. doi: 10.1038/s41431-018-0105-7. Epub 2018 Feb 16.

PMID:
29453419
2.

Premature Ovarian Insufficiency - an update on recent advances in understanding and management.

Torrealday S, Kodaman P, Pal L.

F1000Res. 2017 Nov 29;6:2069. doi: 10.12688/f1000research.11948.1. eCollection 2017. Review.

3.
4.

Reproductive ovarian testing and the alphabet soup of diagnoses: DOR, POI, POF, POR, and FOR.

Pastore LM, Christianson MS, Stelling J, Kearns WG, Segars JH.

J Assist Reprod Genet. 2018 Jan;35(1):17-23. doi: 10.1007/s10815-017-1058-4. Epub 2017 Oct 2. Review.

PMID:
28971280
5.

Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause.

Sullivan SD, Sarrel PM, Nelson LM.

Fertil Steril. 2016 Dec;106(7):1588-1599. doi: 10.1016/j.fertnstert.2016.09.046. Review.

6.

Dysregulation of follicle development in a mouse model of premature ovarian insufficiency.

Grasa P, Sheikh S, Krzys N, Millar K, Janjua S, Nawaggi P, Williams SA.

Reproduction. 2016 Nov;152(5):591-601. Epub 2016 Aug 31.

7.

A clinical research integration special program (CRISP) for young women with primary ovarian insufficiency.

Falorni A, Minarelli V, Eads CM, Joachim CM, Persani L, Rossetti R, Yurttas Beim P, Pellegrini VA, Schnatz PF, Rafique S, Kissell K, Calis KA, Popat V, Nelson LM.

Panminerva Med. 2014;56(4):245-61. Epub 2014 Oct 7. Review.

8.

The FMR1 gene, infertility, and reproductive decision-making: a review.

Pastore LM, Johnson J.

Front Genet. 2014 Jul 7;5:195. doi: 10.3389/fgene.2014.00195. eCollection 2014. Review.

9.

A new approach to primary ovarian insufficiency.

Rafique S, Sterling EW, Nelson LM.

Obstet Gynecol Clin North Am. 2012 Dec;39(4):567-86. doi: 10.1016/j.ogc.2012.09.007. Review.

10.

Impaired production of BMP-15 and GDF-9 mature proteins derived from proproteins WITH mutations in the proregion.

Inagaki K, Shimasaki S.

Mol Cell Endocrinol. 2010 Oct 26;328(1-2):1-7. doi: 10.1016/j.mce.2010.05.017. Epub 2010 Jun 12.

11.

A prospective evaluation of antral follicle function in women with 46,XX spontaneous primary ovarian insufficiency.

Hubayter ZR, Popat V, Vanderhoof VH, Ndubizu O, Johnson D, Mao E, Calis KA, Troendle JF, Nelson LM.

Fertil Steril. 2010 Oct;94(5):1769-74. doi: 10.1016/j.fertnstert.2009.10.023. Epub 2009 Nov 25.

12.

The psychosocial transition associated with spontaneous 46,XX primary ovarian insufficiency: illness uncertainty, stigma, goal flexibility, and purpose in life as factors in emotional health.

Davis M, Ventura JL, Wieners M, Covington SN, Vanderhoof VH, Ryan ME, Koziol DE, Popat VB, Nelson LM.

Fertil Steril. 2010 May 1;93(7):2321-9. doi: 10.1016/j.fertnstert.2008.12.122. Epub 2009 Feb 24.

13.

Clinical practice. Primary ovarian insufficiency.

Nelson LM.

N Engl J Med. 2009 Feb 5;360(6):606-14. doi: 10.1056/NEJMcp0808697. Review. No abstract available.

14.

Ovarian reserve evaluation: state of the art.

de Carvalho BR, Rosa e Silva AC, Rosa e Silva JC, dos Reis RM, Ferriani RA, Silva de Sá MF.

J Assist Reprod Genet. 2008 Jul;25(7):311-22. doi: 10.1007/s10815-008-9241-2. Epub 2008 Aug 5. Review.

15.

Normalization of serum luteinizing hormone levels in women with 46,XX spontaneous primary ovarian insufficiency.

Popat VB, Vanderhoof VH, Calis KA, Troendle JF, Nelson LM.

Fertil Steril. 2008 Feb;89(2):429-33. Epub 2007 May 16.

Supplemental Content

Support Center